Epilepsy is a chronic neurological disease characterized by recurrent epileptic seizures. Studies have shown the complexity of epileptogenesis and ictogenesis, in which immunological processes and epigenetic and structural changes in neuronal tissues have been identified as triggering epilepsy. Cannabidiol (CBD) is a major active component of the Cannabis plant and the source of CBD-enriched products for the treatment of epilepsy and associated diseases. In this review, we provide an up-to-date discussion on cellular and molecular mechanisms triggered during epilepsy crises, and the phytochemical characteristics of CBD that make it an attractive candidate for controlling rare syndromes, with excellent therapeutic properties. We also discuss possible CBD anticonvulsant mechanisms and molecular targets in neurodegenerative disorders and epilepsy. Based on these arguments, we conclude that CBD presents a biotecnological potential in the anticonvulsant process, including decreasing dependence on health care in hospitals, and could make the patient’s life more stable, with regard to neurological conditions.All animals are under the constant threat of attack by parasites. The mere presence of parasite threat can alter behavior before infection takes place. These effects involve pathogen disgust, an evolutionarily conserved affective/emotional system that functions to detect cues associated with parasites and infection and facilitate avoidance behaviors. Animals gauge the infection status of conspecific and the salience of the threat they represent on the basis of various sensory cues. Odors in particular are a major source of social information about conspecifics and the infection threat they present. Here we briefly consider the origins, expression, and regulation of the fundamental features of odor mediated pathogen disgust in rodents. We briefly review aspects of (1) the expression of affective states and emotions and in particular, disgust, in rodents; (2) olfactory mediated recognition and avoidance of potentially infected conspecifics and the impact of pathogen disgust and its’ fundamental features on behavior; (3) pathogen disgust associated trade-offs; (4) the neurobiological mechanisms, and in particular the roles of the nonapeptide, oxytocin, and steroidal hormones, in the expression of pathogen disgust and the regulation of avoidance behaviors and concomitant trade-offs. Understanding the roles of pathogen disgust in rodents can provide insights into the regulation and expression of responses to pathogens and infection in humans.

Acute exposures to outdoor air pollution have been shown to reduce lung function in children with asthma, but the effect on adults with asthma has not been established in a meta-analysis. The objective of this study was to conduct a systematic literature review and meta-analysis of studies that assessed the relationship of outdoor air pollution and peak expiratory flow (PEF) in adults with asthma.

Studies that contained data on outdoor air pollution levels (PM

PM

, or NO

) and PEF in adults with asthma were eligible for inclusion. Effect estimates were quantified for each air pollution measure using random effects models. Heterogeneity was investigated with the Q-test and I

statistics. Meta-regression and subgroup analyses were conducted to determine differences in effect by air pollution measures and the inclusion of smokers.

A total of 22 effect estimates from 15 studies were included in this review. A 10μg/m

increase in acute PM

exposure was associated with a -0.19L/min (95% CI 0.30, -0.09) change in PEF. For both PM

and PM

, the inclusion of current smokers was a significant source of heterogeneity among studies (meta-regression p=0.04 and p=0.03). Among studies that only included non-smokers, a 10μg/m

increase in acute exposure to PM

and PM

was associated with changes in PEF of -0.25L/min (95% CI 0.38, -0.13) and -1.02L/min (95% CI 1.79, -0.24), respectively.

This study provides evidence that acute increases in PM

and PM

levels are associated with decreases in PEF in adults with asthma, particularly among non-smokers.

This study provides evidence that acute increases in PM10 and PM2.5 levels are associated with decreases in PEF in adults with asthma, particularly among non-smokers.The study aims to assess the differences between the chemical profiles of the major anthropogenic and natural PM sources in two areas with different levels of urbanization and traffic density within the same urban agglomeration. A traffic site and an urban background site in the Athens Metropolitan Area have been selected for this comparison. For both sites, eight sources were identified, with seven of them being common for the two sites (Mineral Dust, non-Exhaust Emissions, Exhaust Emissions, Heavy Oil Combustion, Sulfates & Organics, Sea Salt and Biomass Burning) and one, site-specific (Nitrates for the traffic site and Aged Sea Salt for the urban background site). GDC-0068 The similarity between the source profiles was quantified using two statistical analysis tools, Pearson correlation (PC) and Standardized Identity Distance (SID). According to Pearson coefficients five out of the eight source profiles present high (PC > 0.8) correlation (Mineral Dust, Biomass Burning, Sea Salt, Sulfates and Heavy Oil Combustion),gs of this work, that the combined use of both tools can lead the users to a thorough evaluation of the similarity of source profiles. This work is, to the best of our knowledge, the first time a study is focused on the quantitative comparison of the source profiles for sites inside the same urban agglomeration using statistical indicators.Human biomonitoring data provide evidence to exposure of environmental chemicals. Physiologically based pharmacokinetic (PBPK) modelling together with an adequate exposure scenario allows to transpose measured concentrations of chemicals or their metabolites into exposure levels, as daily intakes. In France, high levels of urinary pyrethroids metabolites have been measured in populations. Our work aims at estimating the exposure of the French ENNS cohort to mixtures of four pyrethroids (deltamethrin, permethrin, cypermethrin, and cyfluthrin) from the urinary concentrations of five pyrethroids’ metabolites commonly measured in biomonitoring studies. We developed a modelling approach based on a global toxicokinetic model that accounts for the cumulative exposure to pyrethroids as some of the metabolites can be shared by several parent compounds and for human inter-individual variability in metabolism. The median of the individual daily intakes was estimated to 8.1 ng/kg bw/day for permethrin, 17.7 ng/kg bw/day for cypermethrin, 20.